Newstral
Article
bizjournals.com on 2015-01-27 18:23
Auxilium stockholders approve $2.6B sale of company to Endo
Related news
- Endo completes $2.6B purchase of Auxiliumbizjournals.com
- Endo in $130M deal with South African pharmaceutical companybizjournals.com
- Endo changing its management structurebizjournals.com
- GNC stockholders approve partnership with Chinese companybizjournals.com
- Endo buying generic drug maker for $8Bbizjournals.com
- Valeant boosts bid for Salix to fend off Endobizjournals.com
- Endo sells men's health business unit for $1.65Bbizjournals.com
- Endo adds nasal gel to its testosterone therapy portfoliobizjournals.com
- Big payday looming for Auxilium executivesbizjournals.com
- IAA stockholders approve mergerdailyherald.com
- Endo latest company to settle with New York over opioidsSeattle Times
- Cameron stockholders approve Schlumberger acquisitionbizjournals.com
- NorthState stockholders approve proposed mergerbizjournals.com
- Citrix stockholders approve $16.5B acquisitionbizjournals.com
- Stockholders Approve CVS Health’s Acquisition of Aetnawsj.com
- SAIC, Engility stockholders vote to approve mergerbizjournals.com
- Family Dollar stockholders approve Dollar Tree dealThe Wichita Eagle
- Laredo Petroleum stockholders approve reverse stock splitjournalrecord.com
- Marriott Vacations, ILG stockholders approve $4.7B mergerbizjournals.com
- Aetna stockholders approve $69B sale to CVSbizjournals.com